| Primary |
| Asthma |
43.5% |
| Respiratory Distress |
9.2% |
| Chronic Obstructive Pulmonary Disease |
8.4% |
| Cough |
3.8% |
| Emphysema |
3.8% |
| Product Used For Unknown Indication |
3.8% |
| Blood Pressure Increased |
3.1% |
| Bronchitis |
3.1% |
| Dyspnoea |
3.1% |
| Rhinitis Allergic |
3.1% |
| Bronchospasm |
2.3% |
| Prophylaxis Of Neural Tube Defect |
2.3% |
| Crohn's Disease |
1.5% |
| Drug Use For Unknown Indication |
1.5% |
| Maternal Therapy To Enhance Foetal Lung Maturity |
1.5% |
| Premature Labour |
1.5% |
| Status Asthmaticus |
1.5% |
| Wheezing |
1.5% |
| Abdominal Pain Upper |
0.8% |
| Anxiety |
0.8% |
|
| Drug Ineffective |
11.1% |
| Throat Irritation |
9.5% |
| Hyperthermia Malignant |
7.9% |
| Wrong Technique In Drug Usage Process |
7.9% |
| Cerebellar Infarction |
6.3% |
| Asthma |
4.8% |
| Drug Toxicity |
4.8% |
| Product Quality Issue |
4.8% |
| Respiratory Failure |
4.8% |
| Ventricular Tachycardia |
4.8% |
| Wheezing |
4.8% |
| Atrial Septal Defect |
3.2% |
| Cerebrovascular Accident |
3.2% |
| Cough |
3.2% |
| Cystitis Haemorrhagic |
3.2% |
| Dyspnoea |
3.2% |
| Heart Rate Increased |
3.2% |
| Oral Pain |
3.2% |
| Rash Papular |
3.2% |
| Throat Tightness |
3.2% |
|
| Secondary |
| Asthma |
30.6% |
| Chronic Obstructive Pulmonary Disease |
10.3% |
| Wheezing |
10.3% |
| Cough |
9.1% |
| Drug Use For Unknown Indication |
6.7% |
| Product Used For Unknown Indication |
5.6% |
| Emphysema |
5.2% |
| Respiratory Distress |
3.6% |
| Depression |
2.4% |
| Infection |
2.4% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Cardiac Disorder |
1.6% |
| Pain |
1.6% |
| Toothache |
1.6% |
| Arthralgia |
1.2% |
| Back Pain |
1.2% |
| Bronchitis |
1.2% |
| Musculoskeletal Pain |
1.2% |
| Pain In Extremity |
1.2% |
| Sleep Disorder |
1.2% |
|
| Oropharyngeal Pain |
36.5% |
| Drug Ineffective |
14.3% |
| Asthma |
6.3% |
| Throat Irritation |
6.3% |
| Confusional State |
3.2% |
| Cough |
3.2% |
| Inappropriate Antidiuretic Hormone Secretion |
3.2% |
| Product Quality Issue |
3.2% |
| Rash Papular |
3.2% |
| Respiratory Failure |
3.2% |
| Weight Increased |
3.2% |
| Abdominal Discomfort |
1.6% |
| Abdominal Pain |
1.6% |
| Angioedema |
1.6% |
| Cerebral Haemorrhage |
1.6% |
| Childhood Depression |
1.6% |
| Condition Aggravated |
1.6% |
| Death |
1.6% |
| Exercise Tolerance Decreased |
1.6% |
| Febrile Convulsion |
1.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.0% |
| Asthma |
11.1% |
| Drug Use For Unknown Indication |
10.4% |
| Chronic Obstructive Pulmonary Disease |
8.5% |
| Hypertension |
6.0% |
| Hepatitis C |
3.6% |
| Pain |
3.6% |
| Depression |
2.3% |
| Anxiety |
2.0% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Dyspnoea |
1.7% |
| Nuclear Magnetic Resonance Imaging |
1.7% |
| Nuclear Magnetic Resonance Imaging Abdominal |
1.7% |
| Prophylaxis |
1.7% |
| Diabetes Mellitus |
1.5% |
| Wheezing |
1.5% |
| Premedication |
1.4% |
| Prophylaxis Against Transplant Rejection |
1.3% |
| Anaemia |
1.0% |
| Chronic Lymphocytic Leukaemia |
1.0% |
|
| Urticaria |
8.8% |
| Dyspnoea |
7.4% |
| Pneumonia |
7.4% |
| Vomiting |
6.8% |
| Weight Decreased |
6.8% |
| Pulmonary Embolism |
5.4% |
| Subcutaneous Nodule |
5.4% |
| Weight Increased |
5.4% |
| Myocardial Infarction |
4.7% |
| Wheezing |
4.7% |
| Asthma |
4.1% |
| Death |
4.1% |
| Drug Ineffective |
4.1% |
| Nausea |
4.1% |
| Violence-related Symptom |
4.1% |
| Atrial Fibrillation |
3.4% |
| Pancreatitis |
3.4% |
| Skin Lesion |
3.4% |
| Stress |
3.4% |
| Syncope |
3.4% |
|
